VAZYME
Live / Registered — Registered (as of 11 Jun 2024)
What this means for you
Registered since 11 Jun 2024. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 97646125
- Registration number
- 7411324
- Mark type
- Design + words
- Filed
- 25 Oct 2022
- Published for opposition
- 26 Mar 2024
- Registered
- 11 Jun 2024
- Attorney of record
- John Alumit
Goods and services
- Class 005 — Pharmaceuticals: Disinfectants; Vaccines; Chemical preparations for pharmaceutical or medical purposes, namely, for treating cardiovascular diseases, infectious diseases, chronic diseases, reproductive issues, and improving kidney function and stomach function; Diagnostic preparations for medical purposes; Enzyme preparations for medical purposes; Pharmaceutical preparations for treating cardiovascular diseases, infectious diseases and chronic diseases; Reagents for use in medical genetic testing; Vaccine preparations; Chemically treated papers for use in the detection of fecal occult blood; Preparations of microorganisms for medical purposes
Owner
- Vazyme Biotech Co., Ltd., NANJING, JIANGSU, CN
- Vazyme Biotech Co., Ltd., NANJING, JIANGSU, CN
- Vazyme Biotech Co., Ltd., NANJING, JIANGSU, CN
Prior registrations
Prosecution history
- 11 Jun 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 11 Jun 2024 — REGISTERED-PRINCIPAL REGISTER
- 26 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Mar 2024 — PUBLISHED FOR OPPOSITION
- 06 Mar 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Mar 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Feb 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 16 Feb 2024 — SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
- 15 Aug 2023 — NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
- 15 Aug 2023 — LETTER OF SUSPENSION E-MAILED
- 15 Aug 2023 — SUSPENSION LETTER WRITTEN
- 09 Aug 2023 — ASSIGNED TO EXAMINER
- 09 Nov 2022 — NOTICE OF DESIGN SEARCH CODE E-MAILED
- 08 Nov 2022 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 28 Oct 2022 — NEW APPLICATION ENTERED